Comprehension of confidence intervals in audio-visual patient information materials for people with multiple sclerosis (COCO-MS): A web-based randomised controlled, parallel group trial

Author(s):  
Anne C. Rahn ◽  
Karin Riemann-Lorenz ◽  
Anna Alegiani ◽  
Gesa E.A. Pust ◽  
Adrianus van de Roemer ◽  
...  
BMJ Open ◽  
2016 ◽  
Vol 6 (11) ◽  
pp. e012021 ◽  
Author(s):  
Matthew J Ridd ◽  
Kirsty Garfield ◽  
Daisy M Gaunt ◽  
Sandra Hollinghurst ◽  
Niamh M Redmond ◽  
...  

2009 ◽  
Vol 16 (2) ◽  
pp. 248-251 ◽  
Author(s):  
Lahar R Mehta ◽  
Michael P McDermott ◽  
Andrew D Goodman ◽  
Steven R Schwid

We report the results of a single center randomized, double-blind, placebo-controlled, parallel group trial of memantine in adults with multiple sclerosis and spasticity conducted over 12 weeks. Eligible MS patients had to have an Ashworth spasticity rating of 2 or higher in at least one lower extremity muscle group. Subjects were randomized to receive either placebo or memantine 10 mg twice a day. The primary outcome measure for efficacy was the change in Ashworth Spasticity Scale Score. Although well tolerated, memantine treatment did not demonstrate efficacy in treatment of spasticity in this 12-week small exploratory study.


Sign in / Sign up

Export Citation Format

Share Document